Antihistamine Drugs Market Will Generate Record Revenue by 2029

Antihistamine drugs market is anticipated to grow at a CAGR of 8.7% during the forecast period. The rising prevalence of allergies across the globe is a major factor driving the growth of the antihistamine drug market. The rising healthcare expenditure due to increasing disposable income levels and initiatives by public and private organizations towards spreading awareness related to the treatment of various allergic reactions will further expand the antihistamine drugs market during the forecast period. Antihistamines drugs work well to relieve symptoms of different types of allergies, including seasonal (hay fever), perennial allergic rhinitis, and indoor and food allergies. The drug is also found its effective applications in the treatment of a variety of other conditions such as stomach problems, colds, anxiety, and more.

The antihistamine drugs market growth is also backed by the increased approvals of the antihistamine drugs developed by the major pharma companies operating in the market. For instance, in January 2021, JB Chemicals and Pharmaceuticals Ltd., announced that the US FDA had approved an abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg. The medication is used to treat pollen-induced allergic rhinitis and upper respiratory tract allergies. Moreover, in June 2021, nasal antihistamine drugs for nonprescription use got approval from the US FDA to treat seasonal and perennial allergic rhinitis, also known as allergies.

The increase in the number of R&D activities and the introduction of novel drug therapies for the treatment of allergy diseases is expected to bring enormous growth opportunities to the market and will further aid in market expansion. However, the expiration of patented drugs and the introduction of a generic version of drugs are the restraints that may project to affect the market growth.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/antihistamine-drugs-market

Antihistamine Drugs Market- Segmentation

By Type

  • H-1 Receptor Antagonist
  • H-2 Receptor Antagonists

By Application

  • Flu and Cold
  • Allergy
  • Dermatitis
  • Urticaria
  • Others

By End-User

  • Homecare
  • Hospitals and Clinics
  • Others (ACS)

A full report of Antihistamine Drugs Market is available at: https://www.omrglobal.com/industry-reports/antihistamine-drugs-market

Antihistamine Drugs Market– Segment by Region

North America          

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific   

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America

Company Profiles

  • Akorn, Inc.
  • Almirall S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH.
  • Bristol-Myers Squibb Co.
  • Cadila Pharmaceuticals, Ltd.
  • Hoffmann-La Roche, Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Ltd.
  • Meda Consumer Healthcare, Inc.
  • Merck & Co.
  • Mylan N.V.

Reasons to Buy From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

 About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404